University of Salamanca
🇪🇸Spain
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell
Phase 1
- Conditions
- Graft-vs-Host Disease (GVHD)
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2007-03-22
- Lead Sponsor
- University of Salamanca
- Target Recruit Count
- 15
- Registration Number
- NCT00447460
- Locations
- 🇪🇸
University Hospital of Salamanca, Salamanca, Spain
🇪🇸University Clinic of Navarra, Navarra, Pamplona, Spain
🇪🇸Santa Creu i Sant Pau Hospital, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath